Hjem › Rabdomiosarkom › District of Columbia
Kliniske studier for Rabdomiosarkom i District of Columbia
4 studier for Rabdomiosarkom søker deltakere på steder i District of Columbia.
Byer i District of Columbia
Offisiell studietekst (engelsk)
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
- Children's National Hospital, Washington D.C.
- Childrens National Hospital, Washington D.C.
RekruttererFase 1
Alder 1 til 23 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT07172958Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Sibley Memorial Hospital, Washington D.C.
Rekrutterer
Opp til 39 år · Alle kjønn · Oppdatert 13. jul. 2026 · NCT06796543Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 19. mai 2026 · NCT04901702A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
RekruttererFase 2
18 Months – 40 Years · Alle kjønn · Oppdatert 12. aug. 2025 · NCT05135975Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.